Searched for
PHARMACEUTICAL LICENSEES
Drug companies directed to step up vigil on adverse reactionsIndia's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...- Quick access to key HIV drug hinges on waiver of local clinical trials: ExpertsFaster access to HIV drug lenacapavir in India hinges on the waiver of local clinical trials. Six companies, including three from India, ha...
- Pharma industry raises concerns over new Schedule M's impact on cosmetic manufacturingThe pharmaceutical industry, represented by the Federation of Pharma Enterprises (FoPE), has expressed concerns over the government's new S...
- Govt issues guidance paper to strengthen vaccine companies' reporting of adverse eventsThe new report released last week aims to provide guidance to the manufacturers and importers of vaccines in the country so as to strengthe...
- Pharma export council warns Maiden of export certificate suspensionThe Pharmaceuticals Export Promotion Council of India (Pharmexcil) has cautioned Maiden Pharmaceuticals of suspension of its certificate th...
- Pharmexcil suspends Maiden Pharma's membership"Alleged supply of substandard paediatric medicines by your company led to the death of 66 children and has brought bad reputation to the I...
- 19 Indian companies get licence to make Pfizer's oral genericThese include Cipla, Sun Pharma, Laurus Labs, Divi's Laboratories, Glenmark, Emcure, Macleods, SMS Pharmaceuticals, Strides, Torrent, Cadil...
- Gilead announces steps to expand availability of remdesivir in IndiaRemdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory-confirmed COVID-19 in adults and ...
- These are the companies manufacturing COVID-19 drug Remdesivir in India
- Favipiravir and Remdesivir get approval for treatment“Under an accelerated approval process at the Central Drugs Standard Control Organisation (CDSCO), the Subject Expert Committee (SEC) has r...
- BDR in pact to make Gilead drug for CiplaIn late May, BDR had sought the approval of India’s drug regulator to make and sell remdesivir in India without entering into an arrangemen...
- Gilead sign licensing deal for Remdesivir with three Indian companiesET had reported on May 5 that Gilead Sciences was in talks with several Indian companies including Jubilant Life Sciences for a licensing d...
- TRIPS pact won't cover medical devicesA senior World Trade Organisation official has cautioned against countries pursuing policies of import substitution, which will be harmful ...
- Medical Technology Association bats for tax breaks for R&D centresThere are many companies dealing in manufacturing and export of generic pharmaceutical drugs under contract manufacturing arrangement.
- Sufficient stock of swine flu drugs in Maharashtra: FDA chiefHospitals in Maharashtra, both government and semi-government, have sufficient stock of swine flu drugs which are available for free, said ...
- CCI rules out case against Gilead SciencesCCI has rejected a complaint against Gilead Sciences Inc that alleged the US-based pharmaceutical company of abusing its dominant position.
- Gilead Sciences Inc allows 4 Indian pharmaceutical companies Ranbaxy Laboratories, Matrix Laboratories, Hetero Drugs and Strides Arcolab to sell HIV GenericsRanbaxy Laboratories, Matrix Laboratories, Hetero Drugs and Strides Arcolab can make and sell the three drugs in 100 countries by paying ro...
- Glenmark plans cancer drug unit in ArgentinaMid-sized pharma company Glenmark Pharmaceuticals has decided to set up a facility to produce oncology drugs in Buenos Aires in Argentina.
- MNCs marrying into India Inc face patent testMNCs going in for mergers and acquisitions will soon be required to divest some of their patented technologies to a third-party rival .
- Ranbaxy in pact with Gilead for 'Tenofovir'Ranbaxy Laboratories Ltd said on Monday that it has entered into a licensing agreement with US-based Gilead Sciences Inc for manufacturing ...
Load More
